跳至主要内容
临床试验/IRCT201610197978N3
IRCT201610197978N3已完成4 期

Efficacy and Safety Study of Fixed Dose Combination Tablet of Iron Polymaltose and Folic Acid (Tablet Irpo- FA®) in Pregnant Women with Iron Deficiency Anaemia.

abiqasim Industries (Pvt) Ltd.0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • Inclusion Criteria: Pregnant Women in second or third trimester or after 12 weeks of pregnancy, Hb: = 10. 5g/dl after first trimester and serum ferritin levels are below than normal (less than 35 µg/l)

排除标准

  • Patient with a history of non-compliance with iron therapy or allergic to iron preparation.

研究者

发起方
abiqasim Industries (Pvt) Ltd.

相似试验

已完成
3 期
Safety and Efficacy Study of Fixed Dose Combination of Three Antidiabetic Drugs in Comparison to Two Antidiabetic Drugs in Patients with Type 2 Diabetes
CTRI/2016/11/007439Sun Pharma Laboratories Limited301
已完成
3 期
A clinical trial to study the efficacy and safety of combination drugs of chlorthalidone, metoprolol and telmisartan in treatment of high blood pressure with stable coronary artery disease.
CTRI/2016/11/007491Sun Pharma Laboratories Limited254
已完成
3 期
A clinical study to evaluate the effects of Fixed Dose Combination of 2 drugs, Indapamide S.R. (1.5 mg) + Amlodipine (5 mg) in patients with high blood pressure
CTRI/2010/091/000114Serdia Pharmaceuticals India Pvt Ltd240
进行中(未招募)
1 期
Efficacy and Safety of Fixed-Dose Combination atorvastatin/amlodipine/perindopril versus Fixed-Dose Combination of atorvastatin/ amlodipine in Patients with Hypertension and Dyslipidemia.hypertension and dyslipidemiaMedDRA version: 19.0Level: HLTClassification code 10020774Term: Vascular hypertensive disorders NECSystem Organ Class: 100000004866MedDRA version: 19.0Level: LLTClassification code 10058110Term: DyslipidemiaSystem Organ Class: 100000004861
EUCTR2014-005378-12-BGInstitut de Recherche Internationales Servier830
尚未招募
不适用
Efficacy and safety of newer SGLT2 and DPP-IV inhibitors, when given in single pill as combinations versus given as separate pills together, in type 2 diabetes on Metformi
CTRI/2023/02/049730Jawaharlal Nehru Medical college, Aligarh Muslim University